Maintenance treatment with thalidomide after autologous transplantation for myeloma:: Final analysis of a prospective randomized study of the "Intergroupe Francophone du Myelome".

被引:0
|
作者
Attal, M [1 ]
Harousseau, JL [1 ]
Leyvraz, S [1 ]
Doyen, C [1 ]
Hulin, C [1 ]
Benboubker, L [1 ]
Agha, IY [1 ]
Bourhis, JH [1 ]
Garderet, L [1 ]
Sotto, JJ [1 ]
Michallet, M [1 ]
Renaud, M [1 ]
Voillat, L [1 ]
Berthou, C [1 ]
Marit, G [1 ]
Monconduit, M [1 ]
Dumonté, C [1 ]
Caillot, D [1 ]
Mathiot, C [1 ]
Avet-Loiseau, H [1 ]
机构
[1] Hop Purpan, Hematol Serv, Toulouse, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1148
引用
收藏
页码:335A / 335A
页数:1
相关论文
共 50 条
  • [1] Maintenance treatment with thalidomide after autologous transplantation for myeloma: First analysis of a prospective randomized study of the intergroupe Francophone du Myelome (IFM 99 02).
    Attal, M
    Harousseau, JL
    Leyvraz, S
    Doyen, C
    Hulin, C
    Benboubker, L
    Facon, T
    Bourhis, JH
    Garderet, L
    Sotto, JJ
    Michallet, M
    Renaud, M
    Voillat, L
    Berthou, C
    Marrit, G
    Monconduit, M
    Coiffier, B
    Caillot, D
    BLOOD, 2004, 104 (11) : 155A - 155A
  • [2] Lenalidomide After Autologous Transplantation for Myeloma: First Analysis of a Prospective, Randomized Study of the Intergroupe Francophone Du Myelome (IFM 2005 02)
    Attal, Michel
    Harousseau, Jean Luc
    Marit, Gerald
    Caillot, Denis
    Stoppa, Anne Marie
    Benboubker, Lofti
    Facon, Thierry
    Hulin, Cyrille
    Garderet, Laurent
    Lamy, Thierry
    Leyvraz, Serge
    Doyen, Chantal
    Michallet, Mauricette
    Voillat, Laurent
    Dumonte, Charles
    Roussel, Murielle
    Lauwers-Cances, Vallery
    Cristini, Christelle
    Escriva, Chantal
    Petillon, Marie-Odile
    Mathiot, Claire
    Avet-Loiseau, Herve
    Moreau, Philippe
    BLOOD, 2009, 114 (22) : 220 - 221
  • [3] Double autologous transplantation improves survival of multiple myeloma patients: Final analysis of a prospective randomized study of the "Intergroupe Francophone du Myelome" (IFM 94).
    Attal, M
    Harousseau, JL
    Facon, T
    Guilhot, F
    Doyen, C
    Fuzibet, JG
    Monconduit, M
    Hullen, C
    Caillot, D
    Bouabdallah, R
    Voillat, L
    Sotto, JJ
    Grosbois, B
    Bataille, R
    BLOOD, 2002, 100 (11) : 5A - 6A
  • [4] High dose therapy in multiple myeloma: Final analysis of a prospective randomized study of the ''Intergroupe Francais du Myelome'' (IFM 90)
    Attal, M
    Harousseau, JL
    Stoppa, AM
    Sotto, JJ
    Fuzibet, G
    Rossi, JF
    Casassus, P
    Thyss, A
    Maisonneuve, H
    Facon, T
    Ifrah, N
    Payen, C
    Bataille, R
    BLOOD, 1995, 86 (10) : 485 - 485
  • [5] Autologous Transplantation for Multiple Myeloma in the Era of New Drugs: A Phase III Study of the Intergroupe Francophone Du Myelome (IFM/DFCI 2009 Trial)
    Attal, Michel
    Lauwers-Cances, Valerie
    Hulin, Cyrille
    Facon, Thierry
    Caillot, Denis
    Escoffre, Martine
    Arnulf, Bertrand
    Macro, Margaret
    Belhadj, Karim
    Garderet, Laurent
    Roussel, Murielle
    Mathiot, Claire
    Avet-Loiseau, Herve
    Munshi, Nikhil C.
    Richardson, Paul G.
    Anderson, Kenneth C.
    Harousseau, Jean Luc
    Moreau, Philippe
    BLOOD, 2015, 126 (23)
  • [6] Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myelome
    Yakoub-Agha, Ibrahim
    Mary, Jean-Yves
    Hulin, Cyrille
    Doyen, Chantal
    Marit, Gerald
    Benboubker, Lotfi
    Voillat, Laurent
    Moreau, Philippe
    Berthou, Christian
    Stoppa, Anne-Marie
    Maloisel, Frederic
    Rodon, Philippe
    Dib, Mamoun
    Pegourie, Brigitte
    Casassus, Philippe
    Slama, Borhane
    Damaj, Ghandi
    Zerbib, Robert
    Harousseau, Jean-Luc
    Mohty, Mohamad
    Facon, Thierry
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 88 (03) : 249 - 259
  • [7] Agreement study between the response criteria of the international Myeloma Working Group vs the Intergroupe Francophone du Myelome
    Melero Lopez, D.
    Liria Gonzalez, I.
    Barbosa De Carvalho, N. M.
    Tejedor Diaz, C.
    Puerta Fonolla, P.
    CLINICA CHIMICA ACTA, 2019, 493 : S420 - S421
  • [8] Single versus double transplantation in myeloma: A prospective randomized trial of the Inter Groupe Francophone du Myelome (IFM).
    Attal, MM
    Harousseau, JLJL
    Facon, TT
    Michaux, JLJI
    Guilhot, FF
    Fruchard, CC
    Fuzibet, JGJG
    Hulin, CC
    Caillot, DD
    Dorvaux, VV
    Cahn, JY
    Grobois, BB
    Stoppa, AMAM
    Ifrah, NN
    Sotto, JJ
    Pignon, BB
    Payen, CC
    BLOOD, 2000, 96 (11) : 557A - +
  • [9] HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA - A PROSPECTIVE RANDOMIZED STUDY OF THE INTERGROUPE-FRANCAIS-DU-MYELOME
    ATTAL, M
    HAROUSSEAU, JL
    STOPPA, AM
    SOTTO, JJ
    FUZIBET, G
    ROSSI, JF
    CASASSUS, P
    THYSS, A
    MAISONNEUVE, H
    FACON, T
    IFRAH, N
    PAYEN, C
    BATAILLE, R
    STEM CELLS, 1995, 13 : 147 - 147
  • [10] HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA - A PROSPECTIVE RANDOMIZED STUDY OF THE INTERGROUPE-FRANCAIS-DU-MYELOME (IFM)
    ATTAL, M
    HAROUSSEAU, JL
    STOPPA, AM
    SOTTO, JJ
    FUZIBET, G
    ROSSI, JF
    CASASSUS, P
    THYSS, A
    MAISONNEUVE, H
    FACON, T
    IFRAH, N
    PAYEN, C
    BATAILLE, R
    BLOOD, 1994, 84 (10) : A386 - A386